How do I know if I have Sandhoff Disease?

TL;DR: Sandhoff disease is a rare, progressive genetic disorder caused by a deficiency of the enzyme hexosaminidase A and B, which leads to the harmful accumulation of fatty substances in the brain and organs. Diagnosis is confirmed through specific biochemical blood tests measuring enzyme activity or genetic testing to identify mutations in the HEXB gene.

What are the early signs and symptoms of Sandhoff disease?

Sandhoff disease is categorized into three clinical forms based on the age of onset: infantile, juvenile, and adult-onset. In the infantile form, which is the most common and severe, symptoms typically emerge between 3 and 6 months of age. Parents may notice a startling reaction to loud noises (hyperacusis), loss of previously acquired motor skills, muscle weakness (hypotonia), and a characteristic "cherry-red spot" on the retina during an eye exam. The juvenile and adult-onset forms of Sandhoff disease present more slowly, often with signs of ataxia (lack of muscle coordination), speech difficulties, tremors, and sometimes psychiatric symptoms. Because these signs can mimic other neurological conditions, identifying the specific pattern of progressive decline is essential for medical investigation.

How is Sandhoff disease diagnosed?

Diagnosing Sandhoff disease requires specialized medical intervention. If you or a loved one are experiencing unexplained neurological regression, a physician should be consulted to order the following investigations:

• Enzyme Assay: A blood test to measure the activity levels of hexosaminidase A and B. In individuals with Sandhoff disease, the activity of both enzymes is severely reduced or absent.


• Genetic Testing: Molecular genetic testing of the HEXB gene confirms the diagnosis by identifying pathogenic variants (mutations) that cause the disorder.


• Ophthalmological Exam: An eye exam can identify the cherry-red spot, which is a hallmark finding in many patients with Sandhoff disease.

When should I seek urgent medical evaluation?

If you observe rapid loss of developmental milestones in a child, such as the inability to sit up, loss of vision, or sudden seizures, you should seek immediate evaluation by a pediatric neurologist. For adults, progressive motor impairment, cognitive decline, or sudden changes in gait and balance that interfere with daily life warrant a prompt referral to a neurologist or a metabolic specialist. Do not wait if symptoms are rapidly escalating, as early clinical assessment is vital for supportive care management.

How do I advocate for myself if my concerns are dismissed?

It is common for families to face diagnostic delays because Sandhoff disease is extremely rare. If your concerns are dismissed, document every symptom with dates and severity levels. Bring printed materials from reputable sources like NIH GARD or DiseaseMaps.org to your appointment to demonstrate the basis of your concern. If you feel your primary care physician is not addressing your neurological symptoms, do not hesitate to request a formal referral to a metabolic geneticist or a tertiary care center that specializes in lysosomal storage disorders.

Next steps

• Consult a neurologist or a metabolic geneticist to discuss your symptom history and request hexosaminidase enzyme testing.


• Connect with the 44 members of the DiseaseMaps.org community who are living with or caring for someone with Sandhoff disease to share experiences and find support.


• Utilize the NIH Genetic and Rare Diseases (GARD) Information Center to find specialized clinics in your region.


• Keep a symptom log to track the progression of neurological or physical changes to share with your medical team.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Sandhoff Disease overview.


• Orphanet: Rare Disease Database (ORPHA:790).


• OMIM (Online Mendelian Inheritance in Man): Entry #268800 (Sandhoff Disease).


• National Tay-Sachs & Allied Diseases Association (NTSAD) support resources.